Serum complement comprises a group of proteins that facilitate immunological and inflammatory responses. The so-called complement cascade involves a series of enzymatic reactions that take place in the blood. There are 9 major components labeled C1 through C9. The cascade can be initiated by various means, especially antigen-antibody complexes. The end-product of the cascade is the so-called membrane attack unit (also called terminal complement component), which creates holes in the membranes of attacking bacteria, thereby causing lysis and death of the cells. CH50 or CH100 are tests for the activity of the complement system. There are also a number of side products of the complement cascade that attract white blood cells and increase the efficiency of certain types of white blood cells to engulf bacteria.
When many bacteria are exposed to fresh serum, complement is activated by an "alternative pathway" that does not require the presence of specific antibodies to the bacteria. C3, one of the major components of the complement cascade binds to these bacteria directly. Bound C3, or some modified form of C3, is able to associate with other members of the complement cascade to form a stable unit capable of activating other complement proteins to form the membrane attack unit.
Typically, other tests that are more specific for the suspected disease are performed first.
Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
|